Our results revealed that CENPA upregulation was correlated with poor outcomes (OS, DSS, RFS, and PFS) and progressive clinico-pathological features including AFP elevation, advanced tumor stage, vascular invasion, and tumor size in HCC patients, which were validated in both GSE14520 and TCGA datasets. Here, AFP is linked to hepatocellular carcinoma.